NovaBridge Biosciences, a biotechnology company, engages in the research and development of immuno-oncology agents for the treatment of cancer in the United States. The company operates through two segments, Oncology and Ophthalmology. Its ...
Q1 2026
Apr 7, 2026
FY 2025
Dec 31, 2025
Q4 2025
Q3 2025
Dec 18, 2025
Q2 2025
Aug 20, 2025